Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Net Margin (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Net Margin for 2 consecutive years, with 70491.32% as the latest value for Q2 2025.

  • Quarterly Net Margin changed N/A to 70491.32% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 40.92% through Dec 2025, up 37376.0% year-over-year, with the annual reading at 5.36% for FY2025, N/A changed from the prior year.
  • Net Margin for Q2 2025 was 70491.32% at Neuphoria Therapeutics, up from 75.08% in the prior quarter.
  • The five-year high for Net Margin was 70491.32% in Q2 2025, with the low at 293.24% in Q4 2024.